ClinicalTrials.Veeva

Menu

Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors

L

Latin American Cooperative Oncology Group (LACOG)

Status

Active, not recruiting

Conditions

Carcinoma;Endocrine
Neuroendocrine Tumors

Treatments

Other: Histologically confirmed neuroendocrine tumor

Study type

Observational

Funder types

Other

Identifiers

NCT05168631
LACOG 0119

Details and patient eligibility

About

Multicenter retrospective longitudinal analytical study of patients with neuroendocrine tumors.

Enrollment

88 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 years or older and with histologically confirmed neuroendocrine tumors;
  • Metastatic or inoperable disease;
  • Patients with clinical information about the therapies received, including exclusive palliative care.

Exclusion criteria

  • Lack of data on survival outcomes and/or details on treatments received.

Trial design

88 participants in 1 patient group

Patients aged 18 years or older with histologically confirmed neuroendocrine tumor
Description:
Metastatic or inoperable disease; Patients with clinical information about the therapies received, including exclusive palliative care;
Treatment:
Other: Histologically confirmed neuroendocrine tumor

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems